ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00122577
Recruitment Status : Terminated
First Posted : July 22, 2005
Last Update Posted : July 28, 2005
Sponsor:
Collaborators:
Bristol-Myers Squibb
Gilead Sciences
Information provided by:
French National Agency for Research on AIDS and Viral Hepatitis